Novo Nordisk plans CNY400M investment company in China

Danish biopharmaceutical firm Novo Nordisk announced plans to invest CNY400 million to set up an investment company in China to integrate its business resources.

“Novo Nordisk announced during the expo that the Danish biopharmaceutical firm plans to invest CNY400 million (USD55.7 million) to set up an investment company to integrate its business r”yicaiglobal.com

• 1 source
• yicaiglobal.comInternational Medical Firms Strike Deals With Chinese Partners at 5th CIIEQian TongxinNov 7, 2022

Summarized from public sources; check the original articles before acting on it.